The premenstrual tension syndrome rating scales: An updated version

Journal of Affective Disorders

Volumn 135, Issue 1-3, 2011, Pages 82-88

  Steiner, Meir ^a,b,c   Peer, Miki ^a,c   MacDougall, Mary ^b   Haskett, Roger ^d  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Clinical assessment screening; Premenstrual dysphoric disorder; Premenstrual syndrome; Questionnaire

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; FEMALE; HUMAN; MENSTRUAL CYCLE; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PREMENSTRUAL TENSION SYNDROME OBSERVER RATING SCALE; PREMENSTRUAL TENSION SYNDROME SELF RATING SCALE; PREMENSTRUAL TENSION SYNDROME VISUAL ANALOGUE SCALE; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; SENSITIVITY AND SPECIFICITY; VISUAL ANALOG SCALE;

ADULT; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; LANGUAGE; MENSTRUAL CYCLE; PAIN MEASUREMENT; PREMENSTRUAL SYNDROME; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; WEIGHTS AND MEASURES;

EID: 80054979845     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2011.06.058     Document Type: Article

References (83)

1. E.P. Ahearn The use of visual analog scales in mood disorders: a critical review J. Psychiatr. Res. 31 1997 569 579
2. R.C. Aitken Measurement of feelings using visual analogue scales Proc. R. Soc. Med. 62 1969 989 993
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed. 1994 Text Revision. American Psychiatric Association Washington, DC
4. A. Bergant, A. Schneider, T. Tran, E. Hacket, M. Lanczik, and M. Steiner Diagnosis of premenstrual disorders Dtsch. Med. Wochenschr. 129 2004 188 192
5. M. Bloch, P.J. Schmidt, T.P. Su, M.B. Tobin, and D.R. Rubinow Pituitary-adrenal hormones and testosterone across the menstrual cycle in women with premenstrual syndrome and controls Biol. Psychiatry 43 1998 897 903
6. C.S. Brown, F.W. Ling, R.N. Andersen, R.G. Farmer, and K.L. Arheart Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial Obstet. Gynecol. 84 1994 779 786
7. D.J. Budeiri, A. Li Wan Po, and J.C. Dornan Clinical trials of treatments of premenstrual syndrome: entry criteria and scales for measuring treatment outcomes Br. J. Obstet. Gynaecol. 101 1994 689 695
8. R.F. Casper, and A.M. Powell Premenstrual syndrome: documentation by a linear analog scale compared with two descriptive scales Am. J. Obstet. Gynecol. 155 1986 862 867
9. R.F. Casper, A. Patel-Christopher, and A.M. Powell Thyrotropin and prolactin responses to thyrotropin-releasing hormone in premenstrual syndrome J. Clin. Endocrinol. Metab. 68 1989 608 612
10. S. Chandraiah, J.L. Levenson, and J.B. Collins Sexual dysfunction, social maladjustment, and psychiatric disorders in women seeking treatment in a premenstrual syndrome clinic Int. J. Psychiatry Med. 21 1991 189 204
11. C.J. Chuong, and B.P. Hsi Effect of naloxone on luteinizing hormone secretion in premenstrual syndrome Fertil. Steril. 61 1994 1039 1044
12. C.J. Chuong, B.P. Hsi, and W.E. Gibbons Periovulatory beta-endorphin levels in premenstrual syndrome Obstet. Gynecol. 83 1994 755 760
13. C.J. Chuong, S.R. Kim, O. Taskin, and I. Karacan Sleep pattern changes in menstrual cycles of women with premenstrual syndrome: a preliminary study Am. J. Obstet. Gynecol. 177 1997 554 558
14. A.H. Clayton Symptoms related to the menstrual cycle: diagnosis, prevalence, and treatment J. Psychiatr. Pract. 14 2008 13 21
15. L.S. Cohen, C. Miner, E.W. Brown, E. Freeman, U. Halbreich, K. Sundell, and S. McCray Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries Obstet. Gynecol. 100 2002 435 444
16. J.T. Condon The premenstrual syndrome: a twin study Br. J. Psychiatry 162 1993 481 486
17. J.T. Condon Investigation of the reliability and factor structure of a questionnaire for assessment of the premenstrual syndrome J. Psychosom. Res. 37 1993 543 551
18. D.G. Critchlow, A.J. Bond, and J. Wingrove Mood disorder history and personality assessment in premenstrual dysphoric disorder J. Clin. Psychiatry 62 2001 688 693
19. D.G. Critchlow, A.J. Bond, and J. Wingrove Women with premenstrual dysphoric disorder do not recall aberrant parenting J. Psychosom. Obstet. Gynaecol. 23 2002 143 146
20. G.B. Cross, J. Marley, H. Miles, and K. Willson Changes in nutrient intake during the menstrual cycle of overweight women with premenstrual syndrome Br. J. Nutr. 85 2001 475 482
21. R.C. Daly, P.J. Schmidt, C.L. Davis, M.A. Danaceau, and D.R. Rubinow Effects of gonadal steroids on peripheral benzodiazepine receptor density in women with PMS and controls Psychoneuroendocrinology 26 2001 539 549
22. R.F. Deicken Verapamil treatment of premenstrual syndrome Biol. Psychiatry 24 1988 689 692
23. E. Eriksson, A. Ekman, S. Sinclair, K. Sörvik, C. Ysander, U.B. Mattson, and H. Nissbrandt Escitalopram administered in the luteal phase exerts a marked and dose-dependent effect in premenstrual dysphoric disorder J. Clin. Psychopharmacol. 28 2008 195 202
24. M. Feinberg, B.J. Carroll, P.E. Smouse, and S.G. Rawson The Carroll rating scale for depression III. Comparison with other rating instruments Br. J. Psychiatry 138 1981 205 209
25. K.R. Fontaine, and A. Seal Optimism, social support, and premenstrual dysphoria J. Clin. Psychol. 53 1997 243 247
26. G. Gerhardsen, A.V. Hansen, M. Killi, G.G. Fornitz, F. Pedersen, and S.B. Roos The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study Adv. Ther. 25 2008 595 607
27. P.M. Hahn, D.S. Van Vugt, and R.L. Reid A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome Psychoneuroendocrinology 20 1995 193 209
28. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
29. R.F. Haskett, and J.M. Abplanalp Premenstrual tension syndrome: diagnostic criteria and selection of research subjects Psychiatry. Res. 9 1983 125 138
30. Z. He, R. Chen, Y. Zhou, L. Geng, Z. Zhang, S. Chen, Y. Yao, J. Lu, and S. Lin Treatment for premenstrual syndrome with Vitex agnus castus: a prospective, randomized, multi-center placebo controlled study in China Maturitas 63 2009 99 103
31. K. Khine, D.L. Rosenstein, R.J. Elin, J.E. Niemela, P.J. Schmidt, and D.R. Rubinow Magnesium (mg) retention and mood effects after intravenous mg infusion in premenstrual dysphoric disorder Biol. Psychiatry 59 2006 327 333
32. C. Kirkham, P.M. Hahn, D.A. Van Vugt, J.A. Carmichael, and R.L. Reid A randomized, double-blind, placebo-controlled, cross-over trial to assess the side effects of medroxyprogesterone acetate in hormone replacement therapy Obstet. Gynecol. 78 1991 93 97
33. R.W. Lam, D. Carter, S. Misri, A.J. Kuan, L.N. Yatham, and A.P. Zis A controlled study of light therapy in women with late luteal phase dysphoric disorder Psychiatry. Res. 86 1999 185 192
34. L.J. Lamarche, H.S. Driver, S. Wiebe, L. Crawford, and J.M. DE Koninck Nocturnal sleep, daytime sleepiness, and napping among women with significant emotional/behavioral premenstrual symptoms J. Sleep. Res. 16 2007 262 268
35. M. Landén, H. Nissbrandt, C. Allgulander, K. Sörvik, C. Ysander, and E. Eriksson Placebo-controlled trial comparing intermittent and continuous paroxetine in premenstrual dysphoric disorder Neuropsychopharmacology 32 2007 153 161
36. S. Maddocks, P. Hahn, F. Moller, and R.L. Reid A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome Am. J. Obstet. Gynecol. 154 1986 573 581
37. C.L. Masson, and D.G. Gilbert Cardiovascular and mood responses to quantified doses of cigarette smoke in oral contraceptive users and nonusers J. Behav. Med. 22 1999 589 604
38. M. Mauri, R.L. Reid, and A.W. MacLean Sleep in the premenstrual phase: a self-report study of PMS patients and normal controls Acta. Psychiatr. Scand. 78 1988 82 86
39. C. Maxwell Sensitivity and accuracy of the visual analogue scale: a psycho-physical classroom experiment Br. J. Clin. Pharmacol. 6 1978 15 24
40. M.G. Metcalf, and J.H. Livesey Distribution of positive moods in women with the premenstrual syndrome and in normal women J. Psychosom. Res. 39 1995 609 618
41. M.G. Metcalf, J.H. Livesey, J.E. Wells, and V. Braiden Mood cyclicity in women with and without the premenstrual syndrome J. Psychosom. Res. 33 1989 407 418
42. M.G. Metcalf, J.H. Livesey, J.E. Wells, and V. Braiden Physical symptom cyclicity in women with and without the premenstrual syndrome J. Psychosom. Res. 34 1990 203 213
43. M.G. Metcalf, J.H. Livesey, and J.E. Wells Mood and physical symptom cyclicity in women with the premenstrual syndrome: unexpected response to placebo treatment J. Psychosom. Obstet. Gynaecol. 12 1991 273 289
44. M.G. Metcalf, J.H. Livesey, J.E. Wells, V. Braiden, S.M. Hudson, and L. Bamber Premenstrual syndrome in hysterectomized women: mood and physical symptom cyclicity J. Psychosom. Res. 35 1991 555 567
45. C. Miner, E. Brown, S. McCray, J. Gonzales, and M. Wohlreich Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial Clin. Ther. 24 2002 417 433
46. R.H. Moos The development of a menstrual distress questionnaire Psychosom. Med. 30 1968 853 867
47. C. Novaes, O.P. Almeida, and N.R. de Melo Mental health among perimenopausal women attending a menopause clinic: possible association with premenstrual syndrome? Climacteric 1 1998 264 270
48. B.L. Parry, H. Cover, N. Mostofi, B. LeVeau, P.A. Sependa, A. Resnick, and J.C. Gillin Early versus late partial sleep deprivation in patients with premenstrual dysphoric disorder and normal comparison subjects Am. J. Psychiatry 152 1995 404 412
49. T.B. Pearlstein, G.A. Bachmann, H.A. Zacur, and K.A. Yonkers Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation Contraception 72 2005 414 421
50. J.L. Rausch, D.S. Janowsky, S. Golshan, K. Kuhn, and S.C. Risch Atenolol treatment of late luteal phase dysphoric disorder J. Affect. Disord. 15 1988 141 147
51. L.N. Ravindran, S.A. Woods, M. Steiner, and A.V. Ravindran Symptom-onset dosing with citalopram in the treatment of premenstrual dysphoric disorder (PMDD): a case series Arch. Womens. Ment. Health. 10 2007 125 127
52. N.E. Reame, J.C. Marshall, and R.P. Kelch Pulsatile LH secretion in women with premenstrual syndrome (PMS): evidence for normal neuroregulation of the menstrual cycle Psychoneuroendocrinology 17 1992 205 213
53. R.L. Reid Premenstrual syndrome Curr. Probl. Obstet. Gynecol. Fertil. 8 1985 43 67
54. R.L. Reid, A. Greenaway-Coates, and P.M. Hahn Oral glucose tolerance during the menstrual cycle in normal women and women with alleged premenstrual "hypoglycemic" attacks: effects of naloxone J. Clin. Endocrinol. Metab. 62 1986 1167 1172
55. C.A. Roca, P.J. Schmidt, M.J. Smith, M.A. Danaceau, D.L. Murphy, and D.R. Rubinow Effects of metergoline on symptoms in women with premenstrual dysphoric disorder Am. J. Psychiatry 159 2002 1876 1881
56. P.J. Schmidt, L.K. Nieman, G.N. Grover, K.L. Muller, G.R. Merriam, and D.R. Rubinow Lack of effect of induced menses on symptoms in women with premenstrual syndrome N. Engl. J. Med. 324 1991 1174 1179
57. P.J. Schmidt, G.N. Grover, and D.R. Rubinow Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial Arch. Gen. Psychiatry 50 1993 467 473
58. P.J. Schmidt, G.N. Grover, P.P. Roy-Byrne, and D.R. Rubinow Thyroid function in women with premenstrual syndrome J. Clin. Endocrinol. Metab. 76 1993 671 674
59. P.J. Schmidt, L.K. Nieman, M.A. Danaceau, L.F. Adams, and D.R. Rubinow Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome N. Engl. J. Med. 338 1998 209 216
60. S. Smith, J.S. Rinehart, V.E. Ruddock, and I. Schiff Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial Obstet. Gynecol. 70 1987 37 43
61. M.J. Smith, L.F. Adams, P.J. Schmidt, D.R. Rubinow, and E.M. Wassermann Effects of ovarian hormones on human cortical excitability Ann. Neurol. 51 2002 599 603
62. M.J. Smith, L.F. Adams, P.J. Schmidt, D.R. Rubinow, and E.M. Wassermann Abnormal luteal phase excitability of the motor cortex in women with premenstrual syndrome Biol. Psychiatry 54 2003 757 762
63. M.J. Smith, P.J. Schmidt, T.P. Su, and D.R. Rubinow Gonadotropin- releasing hormone-stimulated gonadotropin levels in women with premenstrual dysphoria Gynecol. Endocrinol. 19 2004 335 343
64. N.A. Spencer, M.K. McClintock, S.A. Sellergren, S. Bullivant, S. Jacob, and J.A. Mennella Social chemosignals from breastfeeding women increase sexual motivation Horm. Behav. 46 2004 362 370
65. C.D. Spielberger, R.L. Gorsuch, and R.E. Lushene STAI Manual 1970 Consulting Psychologists Press Palo Alto, CA
66. M. Steiner, and A. Wilkins Diagnosis and assessment of premenstrual dysphoria Psychiatr. Ann. 26 1996 571 575
67. M. Steiner, R.F. Haskett, and B.J. Carroll Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales Acta. Psychiatr. Scand. 62 1980 177 190
68. M. Steiner, S. Steinberg, D. Stewart, D. Carter, C. Berger, R. Reid, D. Grover, and D. Streiner Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group N. Engl. J. Med. 332 1995 1529 1534
69. M. Steiner, D.L. Streiner, S. Steinberg, D. Stewart, D. Carter, C. Berger, R. Reid, and D. Grover The measurement of premenstrual mood symptoms J. Affect. Disord. 53 1999 269 273
70. M. Steiner, S.J. Romano, S. Babcock, J. Dillon, C. Shuler, C. Berger, D. Carter, R. Reid, D. Stewart, S. Steinberg, and R. Judge The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder B.J.O.G. 108 2001 462 468
71. M. Steiner, M. Macdougall, and E. Brown The premenstrual symptoms screening tool (PSST) for clinicians Arch. Womens Ment. Health 6 2003 203 209
72. M. Steiner, D.L. Streiner, and B. Pham Validation of a revised visual analog scale for premenstrual mood symptoms: results from prospective and retrospective trials Can. J. Psychiatry 50 2005 327 332
73. M. Steiner, A.V. Ravindran, J.M. LeMelledo, D. Carter, J.O. Huang, A.M. Anonychuk, and S.D. Simpson Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women J. Clin. Psychiatry 69 2008 991 998
74. D.L. Streiner A checklist for evaluating the usefulness of rating scales Can. J. Psychiatry 38 1993 140 148
75. T.P. Su, P.J. Schmidt, M. Danaceau, D.L. Murphy, and D.R. Rubinow Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls J. Clin. Endocrinol. Metab. 82 1997 1220 1228
76. T.P. Su, P.J. Schmidt, M.A. Danaceau, M.B. Tobin, D.L. Rosenstein, D.L. Murphy, and D.R. Rubinow Fluoxetine in the treatment of premenstrual dysphoria Neuropsychopharmacology 16 1997 346 356
77. O. Taskin, R. Gökdeniz, A. Yalcinoglu, A. Buhur, F. Burak, R. Atmaca, and U. Ozekici Placebo-controlled cross-over study of effects of tibolone on premenstrual symptoms and peripheral beta-endorphin concentrations in premenstrual syndrome Hum. Reprod. 13 1998 2402 2405
78. K. Winther, and C. Hedman Assessment of the effects of the herbal remedy femal on the symptoms of premenstrual syndrome: a randomized, double blind, placebo-controlled study Curr. Ther. Res. 63 2002 344 353
79. World Health Organization Mental, behavioural and developmental disorders 10th Revision of the International Classification of Diseases (ICD-10) 1996 World Health Organization Geneva
80. K.A. Yonkers, B.N. Hunter, K.M. Bellew, T.E. Rolfe, M. Steiner, and V.L. Heller Paroxetine controlled release is effective in treating premenstrual dysphoric disorder: a pooled analysis of three trials Obstet. Gynecol. 101 2003 110S 111S
81. K.A. Yonkers, C. Brown, T.B. Pearlstein, M. Foegh, C. Sampson-Landers, and A. Rapkin Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder Obstet. Gynecol. 106 2005 492 501
82. K.A. Yonkers, G.A. Holthausen, K. Poschman, and H.B. Howell Symptom-onset treatment for women with premenstrual dysphoric disorder J. Clin. Psychopharmacol. 26 2006 198 202
83. M. Zuckerman, and B. Lubin Normative data for the Multiple Affect Adjective Checklist Psychol. Rep. 16 1965 438